Clinical Trial

Effect of Vitamin D Supplementation on Metabolic Parameters in Patients With Type 2 Diabetes and Vitamin D Deficiency

Study acronym: VITD-DM2
Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical study is to learn whether vitamin D supplementation improves metabolic control in adults with type 2 diabetes mellitus who have vitamin D deficiency. The main questions it aims to answer are: Does vitamin D supplementation improve fasting glucose and glycated hemoglobin (HbA1c) levels in patients with type 2 diabetes and vitamin D deficiency? Does vitamin D supplementation increase serum vitamin D concentrations in these patients? Researchers will evaluate metabolic parameters before and after vitamin D supplementation to assess changes associated with correction of vitamin D deficiency. Participants will: Receive oral vitamin D supplementation (100,000 IU once monthly) for three months Have fasting glucose, HbA1c, body mass index (BMI), and serum vitamin D levels measured at baseline and after three months of supplementation.
Trial Details
NCT Number NCT07468721
Lead Sponsor Faculty of Medical Sciences, Clinical Hospital
Conditions Type 2 Diabetes Mellitus (T2DM), Vitamin D Deficiency
Enrollment 119 participants
Start Date 2024-05-07
Primary Completion 2024-09-30 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-12